Tectonic Therapeutic (TECX) Enterprise Value (2017 - 2026)
Tectonic Therapeutic (TECX) reported Enterprise Value of -$236.9 million for Q1 2026, up 22.65% year-over-year from -$193.2 million in Q1 2025, and up 6.88% quarter-over-quarter from -$254.4 million in Q4 2025.
Tectonic Therapeutic (TECX) Enterprise Value (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 10 years of Enterprise Value data on file, last reported at -$236.9 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$236.9 million, up 22.65% year-over-year; the trailing twelve-month figure through Mar 2026 was -$236.9 million (up 22.65% YoY), and the FY2025 annual result was -$254.4 million, down 80.11% from the prior year.
- Enterprise Value grew to -$236.9 million in Q1 2026 per TECX's latest filing, from -$254.4 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$6.6 million in Q3 2023 and troughed at -$306.2 million in Q1 2025.
- A 5-year average of -$146.2 million and a median of -$141.2 million in 2024 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2023 and 2024: Enterprise Value surged 94.32% in 2023, then plunged 2305.79% in 2024.
- A 5-year view of Enterprise Value shows it stood at -$92.8 million in 2022, then surged by 68.71% to -$29.1 million in 2023, then plunged by 386.16% to -$141.2 million in 2024, then tumbled by 80.11% to -$254.4 million in 2025, then climbed by 6.88% to -$236.9 million in 2026.
- Business Quant data shows TECX's Enterprise Value at -$236.9 million in Q1 2026, -$254.4 million in Q4 2025, and -$269.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -584.73 Mn |
| 10 | Tectonic Therapeutic | 528.16 Mn | 291.27 Mn | - | -236.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -236.89 Mn |
| Dec 31, 2025 | -254.39 Mn |
| Sep 30, 2025 | -268.99 Mn |
| Jun 30, 2025 | -287.40 Mn |
| Mar 31, 2025 | -306.25 Mn |
| Dec 31, 2024 | -141.24 Mn |
| Sep 30, 2024 | -159.10 Mn |
| Jun 30, 2024 | -185.12 Mn |
| Mar 31, 2024 | -19.03 Mn |
| Dec 31, 2023 | -29.05 Mn |
| Sep 30, 2023 | -6.61 Mn |
| Jun 30, 2023 | -15.22 Mn |
| Mar 31, 2023 | -72.33 Mn |
| Dec 31, 2022 | -92.85 Mn |
| Sep 30, 2022 | -116.46 Mn |
| Jun 30, 2022 | -132.41 Mn |
| Mar 31, 2022 | -161.66 Mn |
| Dec 31, 2021 | -189.57 Mn |
| Sep 30, 2021 | -201.37 Mn |
| Jun 30, 2021 | -226.44 Mn |